FDA Approves Sorilux for Adolescent Plaque Psoriasis
The US Food and Drug Administration (FDA) has approved SORILUX (calcipotriene) Foam, 0.005% in adolescents.
Tag: plaque psoriasis
All
LatestSorry, No Posts Found
All
Latest
Phase 3 Trial Shows Injectable Treatment Reduces Submental Fat
The injectable treatment showed a 30-percentage-point advantage over placebo in submental fat responder rates after a single treatment cycle, supporting plans for a regulatory filing in China by year-end.
